Last reviewed · How we verify

chromium nicotinate

Johane Allard · FDA-approved active Small molecule Quality 5/100

chromium nicotinate is a Small molecule drug developed by Johane Allard. It is currently FDA-approved.

At a glance

Generic namechromium nicotinate
SponsorJohane Allard
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about chromium nicotinate

What is chromium nicotinate?

chromium nicotinate is a Small molecule drug developed by Johane Allard.

Who makes chromium nicotinate?

chromium nicotinate is developed and marketed by Johane Allard (see full Johane Allard pipeline at /company/johane-allard).

What development phase is chromium nicotinate in?

chromium nicotinate is FDA-approved (marketed).

Related